Literature DB >> 1621507

The effect of age and Alzheimer's disease on pyramidal neuron density in the individual fields of the hippocampal formation.

D C Davies1, N Horwood, S L Isaacs, D M Mann.   

Abstract

Pyramidal neuron density was determined at autopsy in the brains of 12 neurologically normal patients (age range 6-87 years) and 18 patients with histopathologically confirmed Alzheimer's disease (AD; age range 62-89 years). Paraffin wax sections were cut at the level of the central part of the cornu ammonis and stained with cresyl fast violet. Pyramidal neuron density was determined in the stratum pyramidale of the presubiculum, subiculum, prosubiculum and CA1-4. The width of the stratum pyramidale in these areas was also determined. There was no significant effect of age on pyramidal neuron density in any of the fields of the hippocampal formation. However, there was a significant decrease in pyramidal neuron density in the subiculum (44%), prosubiculum (28%) and CA1 (41%) of AD brains compared to controls. There was no significant effect of AD on pyramidal neuron density in the presubiculum, CA2 and CA3, but in CA4 it increased (23%) significantly. Pyramidal band width decreased significantly with age in the presubiculum but there was no effect of age on any other region of the hippocampal formation investigated. The width of the stratum pyramidale was significantly lower in the presubiculum (19%), subiculum (30%) and CA3 (17%) of AD compared with control brains. These data suggest that a reduction in pyramidal neuron density within the hippocampal formation does not occur in the absence of underlying pathology. In AD, pyramidal neuron loss predominantly occurs from that sector of the hippocampal formation which comprises the subiculum, prosubiculum and CA1.

Entities:  

Mesh:

Year:  1992        PMID: 1621507     DOI: 10.1007/bf00310028

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  34 in total

1.  Loss of recent memory after bilateral hippocampal lesions.

Authors:  W B SCOVILLE; B MILNER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer's disease.

Authors:  P H Gibson; B E Tomlinson
Journal:  J Neurol Sci       Date:  1977-08       Impact factor: 3.181

3.  A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: I. Convergence in the entorhinal, prorhinal, and perirhinal cortices.

Authors:  R C Saunders; D L Rosene
Journal:  J Comp Neurol       Date:  1988-05-08       Impact factor: 3.215

4.  Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone.

Authors:  B T Hyman; G W Van Hoesen; A R Damasio
Journal:  Ann Neurol       Date:  1987-07       Impact factor: 10.422

5.  Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  J Neurol Sci       Date:  1985-07       Impact factor: 3.181

6.  Hippocampal pyramidal cells and aging in the human: a quantitative study of neuronal loss in sectors CA1 to CA4.

Authors:  R B Mani; J B Lohr; D V Jeste
Journal:  Exp Neurol       Date:  1986-10       Impact factor: 5.330

7.  Changes in cell density within the human hippocampal formation as a function of age.

Authors:  K O Devaney; H A Johnson
Journal:  Gerontology       Date:  1984       Impact factor: 5.140

8.  The effect of advanced old age on the neurone content of the cerebral cortex. Observations with an automatic image analyser point counting method.

Authors:  J M Anderson; B M Hubbard; G R Coghill; W Slidders
Journal:  J Neurol Sci       Date:  1983-02       Impact factor: 3.181

9.  Non-hippocampal cortical projections from the entorhinal cortex in the rat and rhesus monkey.

Authors:  K C Kosel; G W Van Hoesen; D L Rosene
Journal:  Brain Res       Date:  1982-07-29       Impact factor: 3.252

10.  Memory and aging: the role of retrieval processes.

Authors:  D M Burke; L L Light
Journal:  Psychol Bull       Date:  1981-11       Impact factor: 17.737

View more
  23 in total

1.  Calcium-Sensitive Translocation of Calmodulin and Neurogranin between Soma and Dendrites of Mouse Hippocampal CA1 Neurons.

Authors:  Kuo-Ping Huang; Freesia L Huang
Journal:  ACS Chem Neurosci       Date:  2011-03-10       Impact factor: 4.418

2.  Increased hippocampal neurogenesis in Alzheimer's disease.

Authors:  Kunlin Jin; Alyson L Peel; Xiao Ou Mao; Lin Xie; Barbara A Cottrell; David C Henshall; David A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

3.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Agonist-induced restoration of hippocampal neurogenesis and cognitive improvement in a model of cholinergic denervation.

Authors:  Jackalina M Van Kampen; Christopher B Eckman
Journal:  Neuropharmacology       Date:  2009-12-22       Impact factor: 5.250

Review 5.  Quantitative sodium MR imaging: A review of its evolving role in medicine.

Authors:  Keith R Thulborn
Journal:  Neuroimage       Date:  2016-11-24       Impact factor: 6.556

6.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.

Authors:  L Buée; P R Hof; C Bouras; A Delacourte; D P Perl; J H Morrison; H M Fillit
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Quantitative sodium MRI of the human brain at 9.4 T provides assessment of tissue sodium concentration and cell volume fraction during normal aging.

Authors:  Keith Thulborn; Elaine Lui; Jonathan Guntin; Saad Jamil; Ziqi Sun; Theodore C Claiborne; Ian C Atkinson
Journal:  NMR Biomed       Date:  2015-06-09       Impact factor: 4.044

Review 8.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

9.  Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice.

Authors:  Kunlin Jin; Veronica Galvan; Lin Xie; Xiao Ou Mao; Olivia F Gorostiza; Dale E Bredesen; David A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

10.  In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic.

Authors:  A Stieber; Z Mourelatos; N K Gonatas
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.